Navco Pharmaceuticals IncTSXV:NAV
- LAST PRICE0.0250
- TODAY'S CHANGE (%)-0.0100 (-28.5714%)
- Bid / Lots0.0250/ 90
- Ask / Lots0.0350/ 132
- Open / Previous Close0.0250 / 0.0350
- Day Range
- 52 Week Range
- Volume4,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NAV |
|---|---|---|
| 09:32 ET | 4000 | 0.025 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Navco Pharmaceuticals Inc | 2.0M | -8.1x | --- |
Company Information
Navco Pharmaceuticals Inc. is a Canada-based company. The Company is engaged in developing and commercializing products to protect against viruses, bacteria, and infectious diseases. It manufactures and researches nanotechnology products and materials using Computerized Nano-meter Algorithms (CNA). The Company's pipeline of applications is tailored to defend against microorganisms such as viruses, bacteria, fungi, and genetic manipulation tools such as clustered regularly interspaced short palindromic repeats (CRISPR). Its target markets include human health and personal skin care, household and institutional products and veterinary health. It offers multiple main product lines, namely, an aerosol spray, hand sanitizer, hand cream, and nano BioGuard-Silver. It also offers sublingual strips (the MunoStrips) infused with immune-boosting compounds to help maintain immune function and help support the body’s metabolism.
Contact Information
- Headquarters
- Suite 1500, 1055 West Georgia StreetVancouver, BC, Canada V6E 4N7
- Phone
- 604-307-8290
- Fax
- 604-909-2679
Executives
- Chief Executive Officer
- Geoffrey Lee
- Chief Financial Officer
- Christopher Cooper
- Chief Operating Officer, Director
- Marek Jasinski
- Corporate Secretary, Director
- Thomas Jusdanis
- Independent Director
- Jatinder Dhaliwal
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 57.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.00 |
Book Value | $0.00 |
P/E Ratio | -8.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | 3.5x |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
